A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma

Clinical trial NCT00725634 · COMPLETED

Trial details

NCT number: NCT00725634
Sponsor: AVEO Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumor Lymphomas Multiple Myeloma

Start date: 2008-09-01
Primary completion: 2010-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.